| 1 |
33525578 | Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting. | 2021 Jan 28 |
1 |
| 2 |
34200197 | Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain. | 2021 Jun 7 |
1 |
| 3 |
17210714 | [177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts. | 2007 Jan 1 |
1 |
| 4 |
17363599 | Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. | 2007 Mar 15 |
2 |